Nigeria Medical Device Procurement: NHIA, Medipool GPO, NAFDAC & Public Health Supply Chain Guide (2026)

Why Nigeria's Medical Device Procurement System Matters

Nigeria is Africa's most populous nation with approximately 230 million people and the continent's largest economy by GDP. Yet the country imports approximately 99% of its medical devices, 70% of its essential medicines, and nearly 100% of its vaccines, according to Dr. Abdu Mukhtar, National Coordinator of the Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC), speaking at the SPAN Innovation 2025 conference.

This extreme import dependence makes Nigeria one of the most significant emerging markets for medical device manufacturers globally. The country's public healthcare system — comprising the National Health Insurance Authority (NHIA), the Basic Health Care Provision Fund (BHCPF), federal tertiary hospitals, and state-level primary healthcare centers — represents a vast and growing procurement ecosystem. In 2025, the federal health budget reached approximately ₦2.56 trillion (~$1.7 billion), while the BHCPF allocation more than doubled to ₦298 billion.

Yet for foreign manufacturers, Nigeria's procurement landscape is uniquely challenging: a complex web of federal and state-level agencies, a nascent national group purchasing organization (Medipool), evolving NAFDAC regulatory requirements, chronic capital budget under-release, foreign exchange volatility, and a government actively pushing to replace imports with local manufacturing. Understanding these dynamics is essential for any manufacturer seeking to access this market.

This guide covers Nigeria's full medical device procurement ecosystem: the institutional architecture, the legal and regulatory framework, NAFDAC registration requirements, the Medipool GPO revolution, the BHCPF funding mechanism, public procurement procedures under the Bureau of Public Procurement (BPP), pricing and reimbursement structures, requirements for foreign suppliers, and practical strategies for market entry.

Nigeria's Healthcare System Overview

A Three-Tier Federal Structure

Nigeria operates a three-tier federal system with healthcare responsibilities divided among the federal government, 36 states, and 774 local government areas (LGAs). The system was restructured by the National Health Act of 2014, which established the legal framework for universal health coverage and created the Basic Health Care Provision Fund.

Tier	Responsibilities	Key Institutions
Federal	National policy, regulation, tertiary hospitals, disease control	Federal Ministry of Health & Social Welfare, NHIA, NAFDAC, NPHCDA
State	Secondary hospitals, primary healthcare delivery, state-level procurement	State Ministries of Health, State Primary Health Care Boards
Local Government	Primary healthcare facilities, community health services	Local Government Health Authorities

Health Insurance Architecture

Nigeria's health insurance system is transitioning from voluntary to near-universal coverage under the National Health Insurance Authority Act of 2022 (which replaced the 1999 NHIS Act and made health insurance mandatory):

Scheme	Administrator	Population Target	Funding
Formal Sector Social Health Insurance (FSSHIP)	NHIA via HMOs	Public and private formal sector employees	Payroll contributions (employer 10%, employee 5%)
Vulnerable Group Fund / BHCPF	NHIA via State Health Insurance Schemes	Poor, vulnerable, informal sector	Federal CRF (1%), donor grants, state counterpart funds
State Social Health Insurance	State Health Insurance Agencies	State-level formal and informal sector workers	State-specific contributions and federal transfers
Private Health Insurance	Private HMOs and insurers	High-income individuals and corporate groups	Voluntary premiums

Despite mandatory insurance, enrollment remains low. As of Q3 2025, approximately 21 million Nigerians (~9%) were enrolled in NHIA-managed health insurance schemes — up from fewer than 12 million before the NHIA Act. Including private health insurance, total coverage is estimated at approximately 10% of the population, leaving the vast majority reliant on out-of-pocket spending or free services at public facilities funded through government budgets and donor programs.

Key Market Data

Metric	Value
Population	~230 million (2025)
GDP	~$472 billion (2022)
Federal health budget (2025)	₦2.56 trillion (~$1.7 billion)
BHCPF allocation (2025)	₦298 billion (~$199 million)
Healthcare share of federal budget	5.15% (2025); Abuja Declaration target: 15%
Healthcare expenditure per capita (2025)	₦11,724 (~$7.80)
Medical device import dependence	~99%
NAFDAC-registered pharmaceutical manufacturers	~16 functional
Proposed federal health budget (2026)	₦2.48 trillion out of ₦58.47 trillion (4.2%)

NAFDAC Regulatory Requirements for Medical Devices

Regulatory Framework

The National Agency for Food and Drug Administration and Control (NAFDAC) is Nigeria's regulatory authority for medical devices, pharmaceuticals, and IVDs. NAFDAC operates under the general statutory mandate of the NAFDAC Act and has historically regulated devices through registration guidelines rather than a dedicated legislative framework. In November 2025, NAFDAC was admitted as the 24th member of the International Council for Harmonisation (ICH) — a significant recognition of its regulatory modernization, placing it among only 25 member national regulatory authorities globally. NAFDAC has also been a member of the International Medical Device Regulatory Forum (IMDRF) since 2023 and achieved WHO ML3 benchmarking in 2022, with successful re-benchmarking in 2025.

In August 2025, NAFDAC published the Draft Medical Devices, including In Vitro Diagnostics and Related Products Regulations, 2025 for stakeholder consultation (comments closed on February 6, 2026). This landmark regulation introduces a structured, risk-based framework covering device classification, clinical investigation, quality management systems, registration, labeling, advertising, post-market surveillance, vigilance, and recall. When finalized, it will replace the existing guidelines-only approach with binding statutory requirements.

Device Classification

Nigeria classifies medical devices into four classes, aligned with the IMDRF framework:

Class	Risk Level	Examples
Class A	Low risk	Bandages, surgical instruments, patient scales, cholesterol test systems
Class B	Low to moderate risk	Surgical gloves, electric hospital beds, surgical lamps, surgical masks, pregnancy self-tests
Class C	Moderate to high risk	ECG machines, X-ray units, syringes, blood glucose self-tests, contact lenses
Class D	High risk	HIV blood donor screening, stents, intraocular lenses, defibrillators, pacemakers

IVDs are separately categorized into general IVDs, self-test IVDs, and high-risk IVDs.

Registration Process

All medical device registration is processed through the NAFDAC Automated Product Administration and Monitoring System (NAPAMS) portal. The standard process involves:

Step 1 — Documentation Screening:

• Application letter to the Director-General (NAFDAC), Attention: Director, VBM-R&RA Directorate
• Notarized Declaration (notarized by a Notary Public in Nigeria for imported devices)
• Power of Attorney or Contract Manufacturing Agreement
• Certificate of Manufacture and Free Sale (authenticated by Nigerian Embassy or High Commission in country of origin)
• ISO 13485 Quality Management System certificate
• Technical documentation in IMDRF format (electronic submission)
• Product labeling and Instructions for Use

Step 2 — Import Permit and Sample Testing:

• Upon successful screening, a Permit to Import is issued electronically via NAPAMS for registration samples
• Samples undergo laboratory testing at NAFDAC-designated laboratories

Step 3 — Registration Decision:

• Standard pathway: Maximum 240 working days from acceptance to registration
• WHO Collaborative Registration Procedure (CRP) pathway: 60 working days (for products with WHO prequalification or approved by reference authorities)
• License validity: 5 years

Registration Fees

Category	Local (NGN)	Foreign (USD)
Category 1 (General medical devices)	₦20,000	$750
Category 2 (Diapers and sanitary pads)	₦20,000	$874

NAFDAC Reliance Guidelines (2025)

In a significant reform effective for 2026 market entry, NAFDAC released the Reliance Guidelines 2025, enabling accelerated approval for products already approved by recognized reference authorities. Eligibility requires:

• Approval from a NAFDAC-recognized regulatory body (e.g., US FDA, EU Notified Bodies, TGA, Health Canada)
• Recent approval date (recent approvals preferred)
• Priority given to drugs, vaccines, and IVDs with public health value

Reliance does not equal automatic approval — NAFDAC retains authority to request additional data, conduct inspections, and impose conditions. However, it can substantially reduce registration timelines for products with established regulatory track records.

Government Procurement Architecture

Institutional Framework

Nigeria's medical device procurement involves multiple federal and state-level institutions:

Institution	Role
Federal Ministry of Health & Social Welfare (FMoHSW)	Health policy, budget allocation, oversight of tertiary hospitals
National Health Insurance Authority (NHIA)	Administers health insurance schemes; procures through NHIA Medicine Supply Initiative (NMSI)
Medipool Nigeria Limited	National Group Purchasing Organisation (GPO); aggregates demand for bulk procurement
Bureau of Public Procurement (BPP)	Regulates all federal public procurement; sets standards; certifies contracts
National Primary Health Care Development Agency (NPHCDA)	Manages BHCPF NPHCDA Gateway (45%); procures for primary healthcare facilities
PVAC (Presidential Initiative for Unlocking the Healthcare Value Chain)	Drives local manufacturing; shapes procurement policy to support domestic production
National Product Supply Chain Management Programme (NPSCMP)	Coordinates health supply chain standards; manages NSCIP integration project
State Ministries of Health	Procure for state secondary hospitals and primary healthcare facilities
Federal Medical Centres and Teaching Hospitals	Conduct their own procurement within BPP guidelines

The Public Procurement Act (2007)

All federal government procurement in Nigeria is governed by the Public Procurement Act (PPA) of 2007, which established the Bureau of Public Procurement (BPP) as the regulatory authority. Key procurement methods include:

Method	Description	When Used
Open Competitive Bidding	Public advertisement; lowest evaluated compliant bid wins	Default method for all procurement
Two-Stage Tendering	Initial technical proposals, then price bids from qualified bidders	When specifications cannot be fully defined upfront; rapid technological change
Restricted Tendering	Limited number of invited bidders (requires BPP approval)	Limited supplier availability; disproportionate evaluation cost
Direct Contracting	Single source procurement (requires BPP approval and justification)	Emergency procurement; proprietary technology; very low value

The BPP Tendering Process

For medical device procurement at federal institutions, the standard open competitive bidding process follows these steps:

1. Procurement planning — The institution (e.g., a Federal Medical Centre) develops annual procurement plans submitted to BPP
2. Budget appropriation — The National Assembly approves the budget. Tender approval takes 3–4 months through the National Assembly
3. Advertisement — The procurement is publicly advertised in at least two national newspapers and on the BPP portal. Suppliers have a minimum of 6 weeks to apply
4. Bid submission — Suppliers submit sealed bids (physical or electronic) with technical and financial components. Bids must be submitted in English
5. Public bid opening — Bids are opened publicly in the presence of bidders, civil society observers, and interested members of the public
6. Evaluation — Technical evaluation followed by financial evaluation. The contract is awarded to the lowest evaluated responsive (compliant) bid
7. BPP certification — For contracts above threshold values, BPP must certify the procurement process before contract award
8. Contract execution and delivery — For imported devices, allow 4–5 weeks for import logistics after contract award

E-Procurement

The BPP is rolling out an electronic Public Procurement (e-PP) platform to digitalize the procurement cycle. The platform has been developed with World Bank support under the Public Sector Governance and Reform Development Project. Key features include:

• P-COMS (Procurement Compliance and Monitoring System): A digital oversight platform for transparency and accountability
• Procurement Management Software (PMS): Web-based tool for procurement planning, accessible to all MDAs
• E-tendering capabilities: Being deployed progressively, with Kaduna and Ekiti states pioneering subnational e-procurement ahead of federal adoption

Medipool: Nigeria's National Group Purchasing Organisation

Overview

In what represents the most significant reform to Nigeria's health commodity procurement in decades, the Federal Executive Council approved Medipool in May 2025, and on February 16, 2026, the Federal Ministry of Health and Social Welfare signed a Memorandum of Understanding and Service Level Agreement to operationalise Medipool as Nigeria's National Group Purchasing Organisation (GPO).

How Medipool Works

Medipool Nigeria Limited is designed to:

Function	Description
Demand aggregation	Pool procurement needs across public and private health facilities nationwide
Bulk purchasing	Negotiate volume-based pricing with manufacturers and suppliers
Price negotiation	Leverage aggregated demand for better contract terms
Quality assurance	Monitor quality standards across the supply chain
Supply chain transparency	Improve visibility and accountability in commodity sourcing and distribution

Implementation Phases

Medipool is being rolled out through a phased implementation strategy:

• Phase 1 (2025–2026): Operationalize through the Basic Health Care Provision Fund (BHCPF) and federal tertiary hospitals. Focus on essential medicines, diagnostics, and high-volume medical consumables
• Phase 2 (2027–2028): Expand to state-level facilities and private health institutions. Integrate with state Drug Management Agencies for last-mile distribution
• Phase 3 (2029+): Full national coverage. Potential to serve as the pooled procurement vehicle for donor-funded programs (USAID, Global Fund, World Bank)

Warehousing and Distribution

The Medipool system will leverage a tiered warehousing infrastructure:

Level	Number	Function
National warehouses	2	Primary storage and distribution hubs
Zonal warehouses	6	Regional distribution across Nigeria's 6 geopolitical zones
State warehouses	37	State-level storage and last-mile distribution

Distribution to health facilities will use federal and state-owned distribution channels, complemented by Public-Private Partnership (PPP) arrangements for last-mile delivery.

Impact on Foreign Suppliers

Medipool's establishment has significant implications for foreign medical device manufacturers:

• Centralized procurement: Instead of selling to hundreds of individual facilities, suppliers can access the national market through Medipool contracts
• Price transparency: Bulk purchasing will drive prices down, requiring competitive pricing strategies
• Local manufacturing preference: Medipool's mandate supports the PVAC goal of 70% local production by 2030, potentially favoring locally manufactured products
• Quality gatekeeping: Medipool will establish quality standards that all suppliers must meet, potentially raising the bar for market entry
• Donor alignment: As Medipool scales, it may replace UNICEF's Wambo.org and other international pooled procurement platforms as Nigeria's primary vehicle for donor-funded procurement

The BHCPF: Funding Primary Healthcare Procurement

Structure and Gateways

The Basic Health Care Provision Fund (BHCPF) was established under Section 11 of the National Health Act (2014) as Nigeria's primary mechanism for funding universal primary healthcare. It is funded by at least 1% of the Federal Consolidated Revenue Fund, supplemented by international donor grants and private sector contributions.

The BHCPF disburses funds through four gateways:

Gateway	Allocation	Administrator	Purpose
NHIA Gateway	48.75%	National Health Insurance Authority	Provides Basic Minimum Package of Health Services (BMPHS) through capitation and fee-for-service payments
NPHCDA Gateway	45%	National Primary Health Care Development Agency	Direct Facility Financing (DFF) for vaccines, essential drugs, consumables, equipment maintenance, and transport
NEMTC Gateway	5%	National Emergency Medical Treatment Committee	Emergency medical treatment services
NCDC Gateway	1.25%	Nigeria Centre for Disease Control	Public health security and epidemic response

BHCPF Allocation Growth

Year	BHCPF Allocation
2024	₦131 billion (~$109 million at 2024 exchange rate)
2025	₦298 billion (~$199 million)
2026 (projected)	Continued growth trajectory

The BHCPF is targeting 17,600 fully functional primary healthcare facilities nationwide by 2027, with at least one in every political ward and at least one secondary healthcare facility per local government area.

BHCPF and Medical Device Procurement

Under the NPHCDA Gateway (45%), funds are used for:

• Essential drugs and medical consumables for primary healthcare centers
• Maintenance and procurement of basic medical equipment
• Vaccine procurement and cold chain equipment
• Transport for supply chain logistics

Under the NHIA Gateway (48.75%), medical devices used in the Basic Minimum Package of Health Services are reimbursed through:

• Capitation payments for primary care services
• Fee-for-service for specific procedures and diagnostics

The PVAC Initiative: Transforming Local Manufacturing

Overview

The Presidential Initiative for Unlocking the Healthcare Value Chain (PVAC) was established by President Bola Ahmed Tinubu in October 2023 to catalyze the transformation of Nigeria's healthcare manufacturing ecosystem. PVAC's ambitious target: produce 70% of healthcare products locally by 2030.

PVAC Strategic Priorities

Priority	Description
Domestic manufacturing	Boost local production of pharmaceuticals, medical devices, diagnostics, and health technologies
Private sector investment	Mobilize domestic and international private capital for healthcare manufacturing
Technology transfer	Facilitate partnerships between Nigerian companies and global manufacturers
Supply chain strengthening	Improve logistics, warehousing, and distribution for health commodities
Market shaping	Create sustainable domestic demand through procurement policies that favor local production
Workforce development	Training programs for pharmaceutical and medical device manufacturing

Key PVAC Actions Affecting Medical Device Procurement

1. Executive Order on Tariff Removal (June 2024): President Tinubu signed an Executive Order removing tariffs, excise duties, and VAT on select pharmaceutical inputs, machinery, and equipment to cut production costs and boost local healthcare manufacturing
2. Manufacturing Academy: Partnership with Empower Swiss to establish a Manufacturing Academy for workforce training in health product manufacturing
3. MoU with Bayer and Chromedix (October 2025): Signed at the Nigeria-EU Health Investment Forum to develop pharmaceutical manufacturing capabilities
4. Local production feasibility studies: Conducting assessments for diagnostic products, malaria commodities, and other health products to identify investment opportunities
5. IFC partnership: Collaborating with the International Finance Corporation to attract private investment into Nigerian healthcare manufacturing

Implications for Foreign Suppliers

PVAC creates both opportunities and challenges for foreign manufacturers:

Aspect	Impact
Tariff incentives for local production	Foreign manufacturers establishing local production benefit from duty-free inputs and machinery
Technology transfer partnerships	Foreign companies partnering with Nigerian firms gain access to preferential procurement policies
Market shaping for local products	Procurement policies increasingly favor domestically manufactured products
Reduced import dependence target	The 70% local production target by 2030 signals a long-term shift away from import dependency
IFC financing support	International manufacturers investing in Nigerian production facilities can access IFC financing

Pricing and Reimbursement

Public Sector Pricing

Pricing in Nigeria's public healthcare system is driven by procurement competition and budget constraints:

Mechanism	Description
Competitive bidding	Lowest evaluated compliant bid wins for government procurement
Medipool negotiated pricing	Bulk purchasing at nationally negotiated prices
BHCPF capitation	Fixed per-capita payments to facilities for primary care services
NHIA fee-for-service	Reimbursed at fixed tariff rates for specific procedures
State-level negotiation	States negotiate separately for their facility procurement

Price Pressures

Nigeria's medical device market faces severe price pressures from multiple directions:

• Currency devaluation: The Naira depreciated sharply from approximately ₦800/$1 in early 2024 to over ₦1,500/$1 by mid-2024, and has since partially recovered to approximately ₦1,350–1,450/$1 in early 2026, dramatically increasing the cost of imported devices
• Drug price inflation: Essential anti-malaria medications rose by over 135% and insulin and some antibiotics by up to 157% in late 2024, driven by inflation and the weakening Naira
• Capital budget under-release: In 2025, only ₦36 million of the ₦218 billion capital budget for health was released — a staggering 0.016% — devastating public hospital capacity to purchase medical equipment
• Out-of-pocket burden: With insurance coverage at only ~10%, most Nigerians pay directly for healthcare, making price a critical factor in purchasing decisions

Reimbursement Under NHIA

The NHIA uses multiple provider payment methods that affect how medical devices are financed:

Payment Method	Application	Device Implication
Capitation	Primary care under BHCPF	Devices absorbed within per-capita facility payments
Fee-for-service	Secondary and tertiary care procedures	Devices reimbursed at NHIA tariff rates per procedure
Case-based payment	Hospital episodes	Similar to DRG; device cost included in episode payment

These payment mechanisms are not yet well harmonized, and the NHIA has experienced over-referrals due to capitation and supplier-induced demand due to fee-for-service, according to research by RESYST and the London School of Hygiene and Tropical Medicine.

Market Access for Foreign Suppliers

Entry Pathways

Strategy	Description	Pros	Cons
Local agent/distributor	Appoint a Nigerian-registered distributor to handle NAFDAC registration and commercial sales	Fastest entry; lowest investment; leverages local knowledge	Limited control; margin sharing; dependency on partner quality
Nigerian subsidiary	Register a local company to hold NAFDAC licenses and manage operations directly	Full control; direct hospital relationships; eligible for local procurement	Higher investment; regulatory complexity; FX repatriation challenges
Manufacturing partnership / JV	Partner with a Nigerian manufacturer for local production	Access to PVAC incentives; tariff exemptions; domestic preference in procurement	Technology transfer required; complex governance; longer setup
Greenfield manufacturing	Establish own manufacturing facility in Nigeria	Maximum PVAC benefits; tariff-free inputs; strongest local position	Highest investment; infrastructure challenges; long timeline
Donor-funded channels	Supply through WHO, UNICEF, Global Fund, USAID procurement	Large-scale orders; USD-denominated; quality-driven	Limited to specific disease programs; complex prequalification

Registration Requirements

Foreign manufacturers must complete these steps to sell medical devices in Nigeria:

1. Appoint a Local Representative: A Nigerian-registered company with a valid NAFDAC license to import medical devices. This entity holds the Power of Attorney from the manufacturer
2. Obtain NAFDAC Establishment License: Register the manufacturing facility with NAFDAC, including GMP inspection
3. Submit product registration via NAPAMS: Complete documentation including Certificate of Free Sale (authenticated by Nigerian Embassy), ISO 13485 certificate, technical documentation, labeling
4. Obtain Import Permit: NAFDAC issues electronic permit for sample importation and testing
5. Complete registration: Obtain 5-year NAFDAC registration certificate
6. Register with BPP: For public procurement eligibility, register on the BPP national database of contractors and suppliers
7. Register on relevant procurement platforms: Depending on target buyers, register on e-procurement platforms, Medipool supplier lists, or state-level procurement databases

Practical Challenges for Foreign Suppliers

Challenge	Description	Mitigation
Foreign exchange access	Obtaining USD through the Central Bank of Nigeria is time-consuming and often at unfavorable rates	Structure contracts in USD where possible; maintain local Naira reserves
Customs and import duties	Medical devices are generally subject to VAT (7.5%) and customs duties (5–20%), unless exempted	Leverage PVAC tariff exemptions for local manufacturing inputs; explore duty waivers for donor-funded programs
Capital budget delays	Government facilities face severe delays in capital budget releases	Focus on recurrent budget items and consumables; diversify to private sector
Regulatory timeline	Standard NAFDAC registration takes up to 240 working days	Use WHO CRP pathway (60 working days) if eligible; begin registration early
Infrastructure challenges	Poor road networks, inadequate cold chain, limited storage facilities	Work with established logistics partners; invest in supply chain infrastructure
Counterfeit products	Substandard and falsified medical products compete in the market	Ensure robust NAFDAC traceability compliance; invest in authentication technology
In-country presence requirement	Public tenders require a local presence to manage the selection process	Maintain a local office or partner with established distributors

Market Opportunities by Segment

Segment	Opportunity Level	Notes
Diagnostic equipment and IVDs	Very High	Extreme import dependence; PVAC actively seeking local diagnostic manufacturing partners
Medical imaging (X-ray, CT, MRI)	High	Government cancer control plan includes imaging expansion; very limited current deployment
Surgical equipment and implants	High	Heavily imported; growing demand from both public and private sectors
Laboratory equipment and reagents	High	16 functional manufacturers exist but utilization is only 30–35%; major gap in supply
Cold chain and vaccine storage	High	Federal immunization program expanding; cold chain equipment demand growing
Digital health and point-of-care diagnostics	High	Strong government interest in telemedicine and digital health solutions
Oxygen and respiratory equipment	High	COVID-19 highlighted critical gaps; oxygen plant investment ongoing
Basic consumables (syringes, gloves)	Moderate	Some local production exists; price-sensitive market
Rehabilitation and assistive devices	Growing	Largely unmet need; no tax exemptions for assistive technology

Emerging Trends (2026)

Medipool Rollout and Procurement Consolidation

The operationalization of Medipool in February 2026 represents a fundamental shift in how Nigeria procures health commodities. Key developments to watch:

• Integration with the BHCPF and federal tertiary hospital procurement
• Migration from fragmented facility-level purchasing to centralized demand aggregation
• Development of national quality standards and supplier prequalification criteria
• Potential to replace international pooled procurement platforms (UNICEF Wambo, Axmed) for Nigeria's domestic needs

NAFDAC Draft Medical Device Regulations

The finalization of the Draft Medical Devices Regulations 2025/2026 will create Nigeria's first comprehensive statutory framework for medical device regulation. Expected changes include:

• Binding legal requirements replacing current guidelines
• Enhanced post-market surveillance and vigilance requirements
• Stricter quality management system requirements
• Clearer obligations for software-enabled medical devices
• Refurbished device regulations with QMS, post-market surveillance, and conformity requirements

NAFDAC Traceability Systems

In 2025, NAFDAC began rolling out traceability systems to combat substandard and falsified medical products. This will increasingly require foreign manufacturers to implement serialization and track-and-trace capabilities for products sold in Nigeria.

Local Manufacturing Push

Nigeria's drive toward local production is accelerating:

• PVAC target: 70% local manufacturing by 2030
• Executive Order incentives: Tariff, excise duty, and VAT removal for pharmaceutical inputs and manufacturing equipment
• IFC and World Bank support: Financing and technical assistance for local manufacturing
• Emerging RDT manufacturing: Projected capacity of 470 million tests per year by 2026, though utilization remains below 40%
• MoU with Bayer and other multinationals: Signaling growing interest in Nigeria-based production

State-Level Healthcare Investment

Individual states are increasingly investing in their own healthcare infrastructure:

• Lagos State Primary Healthcare Revitalization Program: Equipping clinics with essential diagnostic kits and oxygen concentrators
• State health insurance expansion: States establishing their own health insurance agencies under the NHIA framework
• Subnational procurement autonomy: States conducting their own procurement outside the federal system

Practical Checklist for Market Entry

Regulatory Pathway

• Appoint a Nigerian local representative with valid NAFDAC import license
• Prepare technical documentation in IMDRF format
• Authenticate Certificate of Free Sale through Nigerian Embassy in country of origin
• Submit product registration via NAPAMS portal
• Budget 60–240 working days for NAFDAC registration (use CRP pathway if eligible)
• Monitor NAFDAC Draft Regulations finalization for new compliance requirements
• Implement traceability/serialization systems

Public Procurement Pathway

• Register on the BPP national database of contractors and suppliers
• Register on relevant e-procurement platforms (federal and target states)
• Apply for Medipool supplier prequalification as it becomes operational
• Monitor public procurement advertisements in national newspapers and BPP portal
• Prepare competitive pricing (public procurement is lowest-compliant-bid driven)
• Build relationships with Federal Medical Centres and teaching hospital procurement departments
• Allow 3–4 months for tender approval + 6 weeks for bid submission

Commercial Strategy

• Evaluate public vs. private sector focus based on product type and pricing
• For public sector: develop cost-competitive offerings with strong compliance documentation
• For private sector: invest in relationships with private hospital groups and specialist clinics
• Consider local manufacturing partnership to access PVAC incentives and procurement preferences
• Structure contracts to manage foreign exchange risk
• Budget for infrastructure challenges (cold chain, last-mile delivery, storage)
• Diversify across public procurement, donor-funded programs, and private sector channels

Key Takeaways

1. Nigeria imports 99% of its medical devices — With ~230 million people and a rapidly growing healthcare budget, Nigeria represents one of the largest import-dependent medical device markets in the world. The federal health budget reached ₦2.56 trillion in 2025, though it remains far below the Abuja Declaration target of 15% of total government expenditure.

2. Medipool is transforming procurement — Approved by the Federal Executive Council in 2025 and operationalized in February 2026, Medipool is Nigeria's new national GPO. It will aggregate demand across public and private facilities for bulk procurement, price negotiation, and quality assurance, centralizing what has been a fragmented purchasing landscape.

3. NAFDAC registration is required for all medical devices — All devices must be registered through the NAPAMS portal, with timelines of 60 working days (WHO CRP pathway) to 240 working days (standard pathway). A local representative and authenticated Certificate of Free Sale are mandatory. New comprehensive regulations are being finalized in 2025–2026.

4. The BHCPF is the primary funding mechanism for primary healthcare procurement — Funded by 1% of the Consolidated Revenue Fund (₦298 billion in 2025), the BHCPF disburses through four gateways to support 17,600 primary healthcare facilities. It directly finances procurement of essential drugs, consumables, and basic medical equipment.

5. PVAC is actively pushing import substitution — The Presidential Initiative for Unlocking the Healthcare Value Chain aims to achieve 70% local manufacturing by 2030. Foreign manufacturers should consider local production partnerships to access tariff incentives and procurement preferences, or risk being displaced as the policy environment shifts toward domestic suppliers.

6. Severe infrastructure and budget challenges persist — Only ₦36 million of ₦218 billion in capital health budget was released in 2025. Currency devaluation has driven medical device costs up dramatically. With only ~10% of the population covered by health insurance, most patients pay out-of-pocket. Successful market entrants will be those who can navigate these challenges while offering competitive pricing and maintaining quality standards.